Metoprolol withdrawal phenomena: mechanism and prevention.
Eight patients taking metoprolol (300 mg/day) for essential hypertension were studied after abrupt withdrawal and placebo replacement of the drug. A 52% average rebound increase in cardiac chronotropic sensitivity to isoproterenol and 15% rebound rise in resting heart rate occurred in all patients between 2 to 8 days after metoprolol withdrawal (P less than 0.05). Holter monitoring showed no associated arrhythmia. A transient increase in blood pressure occurred in one patient and withdrawal-like symptoms were noted in three patients. There were no meaningful changes in plasma norepinephrine, epinephrine, thyroxine, or triiodothyronine. Seven of the eight patients were again studied serially after the same metoprolol dosing, during a prolonged low-dose withdrawal schedule (50 mg/day for 10 days) and during placebo. Prolonged low dose before complete metoprolol withdrawal decreased but did not completely prevent the changes observed after abrupt withdrawal. The observed rebound of cardiac beta-adrenergic sensitivity may have application to the mechanism and prevention of the beta-blocker syndrome in patients with angina.
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D004334:Drug Administration Schedule; D004837:Epinephrine / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008790:Metoprolol / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D011412:Propanolamines / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control*; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D011412:Propanolamines; D014284:Triiodothyronine; D008790:Metoprolol; D007545:Isoproterenol; D013974:Thyroxine; D009638:Norepinephrine; D004837:Epinephrine